FDANews
www.fdanews.com/articles/189200-fda-clears-new-parameter-for-terumos-blood-monitor
ClearanceStamp_Orange.gif

FDA Clears New Parameter for Terumo’s Blood Monitor

November 15, 2018

The FDA granted clearance to Terumo Cardio’s CDI blood parameter monitoring system to monitor oxygen delivery in real-time.

The device is now approved to measure 12 critical blood parameters.

Measuring oxygen delivery is used during cardiopulmonary bypasses to help reduce acute kidney injury, a common complication of cardiac surgery.

View today's stories